Proteinea
Founded 2020 · 51 employees on LinkedIn · 5 known investors
Find your way into Proteinea
Proteinea uses proprietary AI models and computational tools to engineer antibodies, focusing on rational design of antibody Fc domains for improved efficacy, half-life, and targeted biodistribution. It combines AI-driven design frameworks with wet-lab validation to develop Fc-optimized antibody scaffolds for therapeutic development.
Founders & leadership
Proteinea was founded in 2020 by Abdulaziz Elgammal and Mahmoud Eljendy.
Investors · 5
Frequently asked questions
- What does Proteinea do?
- Proteinea uses proprietary AI models and computational tools to engineer antibodies, focusing on rational design of antibody Fc domains for improved efficacy, half-life, and targeted biodistribution. It combines AI-driven design frameworks with wet-lab validation to develop Fc-optimized antibody scaffolds for therapeutic development.
- Who founded Proteinea?
- Proteinea was founded by Abdulaziz Elgammal, Mahmoud Eljendy in 2020.
- Who are Proteinea's investors?
- Proteinea's investors include 500 Global, Sadu Capital, Sawari Ventures, Shorooq Partners, VentureSouq.